Usi Sukorini
Departement Of Clinical Pathology And Medical Laboratory, Faculty Of Medicine, Public Health And Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Published : 34 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 34 Documents
Search

THE RISK FACTOR OF ALLOANTIBODY FORMATION IN THALASSEMIA PATIENTS RECEIVING MULTIPLE TRANSFUSION (Faktor Kebahayaan Terbentuknya Aloantibodi pada Pasien Talasemia yang Menerima Transfusi Darah Berulang) Fridawati, Veronica; Triyono, Teguh; Sukorini, Usi
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 22, No 3 (2016)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v22i3.1239

Abstract

Untuk kelangsungan hidup pasien talasemia intermediet dan mayor, memerlukan transfusi darah secara teratur. Transfusi berulangini berpeluang membentuk aloantibodi yang dapat menyebabkan kebahayaan hemolitik. Maka transfusi berulang akan memperberathemolitik karena pada pasien talasemia sudah ada proses tersebut. Tujuan penelitian ini adalah untuk mengetahui berbagai faktorkebahayaan untuk terbentuknya aloantibodi pada pasien talasemia yang mendapat transfusi darah berulang khusus di RSUP Fatmawati,Jakarta. Cara meneliti ini menggunakan rancangan potong lintang. Subjek penelitian adalah semua pasien talasemia yang mendapattransfusi darah berulang di RSUP Fatmawati Jakarta yang memenuhi patokan kesertaan. Sebanyak 81 subjek diikutkan dalam penelitianini. Data pada penelitian ini di analisis secara statistik dengan uji Chi Kuadrat. Hasil menguji secara Chi Kuadrat menunjukkan: kelamin,suku, diagnosis, selang transfusi darah, jenis darah, reaksi yang terkait, riwayat keluarga, kadar Hb. Kadar feritin dan golongan darahbukan merupakan faktor kebahayaan untuk terbentuknya aloantibodi, sedang faktor usia, jumlah kantong darah yang ditransfusikan,keberadaan komplikasi akibat transfusi darah dan lama masa waktu menerima darah transfusi, merupakan faktor kebahayaan untukterbentuknya aloantibodi pada pasien talasemia yang mendapat transfusi berulang di RSUP Fatmawati.
Profil Pemeriksaan Fragilitas Osmotik Eritrosit di RS. Dr. Sardjito Gugun, Adang Muhammad; Sukorini, Usi
Mutiara Medika: Jurnal Kedokteran dan Kesehatan Vol 4, No 2 (2004)
Publisher : Universitas Muhammadiyah Yogyakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18196/mmjkk.v4i2.1745

Abstract

Osmotic fragility test (OFT) is performed to differentiate anemia diagnose with erythrocyte physical changing. In thalassemia and hemolytic anemia, OFT probably gave variation results that can cause erroneous anemia etiology trac¬ing. Aims of this research are to describe the OFT profile and its comparison with peripheral blood morphology in thalassemia and hemolytic anemia.The method, this retrospective study was conducted in Dr. Sardjito hospital at January 2002 to June 2004. Chi-Square test was used to compare thalassemia and hemolytic anemia proportion in the OFT groups. OFT results from 61 sub¬jects were : increasing 17 (27,8%), increasing-decreasing 17 (27,8%), de¬creasing 15 (24,4%), and normal 12 (20%). There were significantly differ-ence proportions in thalassemia group between decreasing OFT to increasing and normal OFT (p-0,005 ; p=0,002), but no difference to increasing-de¬creasing group. In hemolytic anemia group, the difference proportion found significantly between increasing OFT to normal, increasing-decreasing and decreasing OFT (p=0,03; p-0,005; p=0,000, respectively). In increasing-de¬creasing OFT group, there was no difference in type anemia (p=0,32). Mor¬phologically, target cell was found in 81 % of thalassemia, and spherocyte in 70% of hemolytic anemia. In Dr. Sardjito Hospital, OFT gave variation profile and in Thalassemia and hemolytic anemia groups, morphology evaluation are needed to confirm OFT results.Latar Belakang: Pemeriksaan fragilitas osmotik eritrosit (FOE) ini dilaksanakan untuk membantu diagnosis banding beberapa jenis anemia dengan sifat fisik eritrosit berubah. Aplikasi klinis, Talasemia dan anemia hemolitik memberikan hasil bervariasi sehingga dapat menimbulkan kesalahan interpretasi dalam melacak jenis maupun etiologi anemia.Tujuan penelitian ini adalah mengetahui variasi hasil FOE dan kesesuaian gambaran morfologi darah tepi pada talasemia dan anemia hemolitik. Penelitian retrospektif ini dilakukan menggunakan data rekam medik. Subyek adalah pasien yang diperiksa fragilitas osmotik eritrositnya di laboratorium Patologi Klinik RS. Dr. Sardjito antara Januari tahun 2002 sampai dengan Juni 2004. Uji Chi- square terhadap proporsi talasemia dan anemia hemolitik pada kelompok hasil FOE. Dari 61 subyek, variasi hasil FOE meliputi : peningkatan fragilitas 17 (27,8%), penurunan fragilitas 17 (24,4%), campuran peningkatan dan penurunan 15 (27,8%) dan normal 12 (20%). Terdapat perbedaan bermakna proporsi talasemia kelompok penurunun FOE terhadap kelompok peningkatan FOE (p=0,005) dan FOE normal (p= 0,002), namun tidak berbeda bermakna dengan hasil campuran penurunan dan peningkatan fragilitas (p= 0,26). Terdapat perbedaan bermakna proporsi ane¬mia hemolitik pada kelompok dengan peningkatan FOE terhadap kelompok normal FOE, campuran penurunan dan peningkatan FOE dan penurunan FOE (p =0,03; p= 0,005; p= 0,000). Tidak terdapat perbedaan bermakna proporsi jenis anemia pada hasil campuran penurunan dan peningkatan FOE (p= 0,32). Gambaran morfologi darah tepi pada kelompok talasemia, 81% memiliki sel target dan pada kelompok anemia hemolitik, 70% memiliki sel spherosit.Hasil FOE di RS Dr. Sardjito menunjukkan gambaran variasi, talasemia maupun anemia hemolitik membutuhkan konfirmasi morfologi darah tepi untuk meninjau kesesuaiannya.
Multiple Myeloma with Suspected Non-Secretory Type Indrarsi, Annisa Ginar; Sukorini, Usi
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 27, No 1 (2020)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v27i1.1575

Abstract

Multiple Myeloma (MM) is a hematological malignancy characterized by clonal plasma cell in bone marrow that produceabnormal globulin, which resulted in monoclonal gammopathy. Multiple Myeloma Non-Secretory (MMNS) is a very rareform of multiple myeloma with monoclonal plasmocytic proliferation in bone marrow supported by clinical manifestationand radiological findings. However, plasma cells fail to secrete immunoglobulin. A 44-year-old female came to SardjitoGeneral Hospital with main complaints of weakness and back pain. General weakness and pale palpebral conjunctiva were6 observed (+/+), liver and spleen were not palpable. Blood test results were as follows: Hb 3.0 g/dL, RBC 1.07 x 10 / μL, WBC3 3 562 x 10 /μL, PLT 114 x 10 /μL, A/G ratio 1.07, BUN 51.5 mg/dL, creatinine 4.62 mg/dL, and calcium 3.1 mmol/L. Skeletalsurvey suggested a multiple osteolytic. Protein electrophoresis revealed hypogammaglobulinemia with no M-spike. Therewere 66% of plasma cells in bone marrow. Patient was diagnosed by MMNS. Diagnosis MMNS can be established if clonalplasmacytes is accompanied with renal insufficiency and hypercalcemia. However, monoclonal gammopathy was not foundin serum protein electrophoresis. A case reported of 44-year-old female diagnosed as MMNS with 'punched out' multipleosteolytic, increased plasma cells in bone marrow without evidence of paraprotein in circulation proved by low A/G ratio andnegative M-spike.
Negative Correlation between cross-linked fibrin degradation products (d-dimer) and glasgow coma scale (GCS) scores in patients with head injury Andriani Tri Susilowati; Usi Sukorini; . Setyawati
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 45, No 02 (2013)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (893.511 KB) | DOI: 10.19106/JMedScie004502201303

Abstract

Traumatic Brain Injury (TBI) is damage in the brain caused by a traumatically injuring external force. To observe its severity, the Glasgow Coma Scale (GCS) and Computed Tomography (CT) scan are used. In addition, D-dimer as an end product of fibrinolytic activity is proposed as the predictor of TBI outcome. The increase of D-dimer value is correlated with severity. CT-scan is too expensive and requires patients’ mobility that can cause worse incidents. The aim of this study was to correlate between D-dimer and GCS in patients with traumatic brain injury. The cross sectional observational analytic design was carried out in the study. The TBI patients with 24 hours onset admitted to Emergency Room Dr. Sardjito Hospital Yogyakarta will be included with inclusion and exclusion criteria consecutively. Glasgow coma scale was measured and plasma D-Dimer was examined using Nycocard with immunofiltration method. Correlation between plasma D-Dimer and Glasgow Coma Scale was tested using Pearson Correlation when the population distribution was normal and Spearman when it was not normally distributed. There was a strong negative correlation between D-dimer and Glasgow Coma Scale (r=-0.622; p<0.001) and Prothrombin Time with D-dimer value (r=0527; p<0.001). Moreover, it was found that haemoglobin had a correlation with D-dimer (r=-0.517; p=0.001). Haemoglobin and PT had a correlation with Glasgow Coma Scale (r=0.419 vs -0.591; p<0.001) and neutrophil had poor correlation with Glasgow Coma Scale (r=-0.336; p=0.034). In conclusion, there was a strong negative correlation between degradation product of cross-linked fibrin (D-dimer) and Glasgow Coma Scale in patients with traumatic brain injury. Keywords: D-Dimer - Glasgow Coma Scale - Traumatic Brain Injury - CT scan - correlation
Prevalence ratio of free fatty acid in obese group with non-alcoholic fatty liver disease Rosmeri Handayani; Siti Muchayat Purnamaningsih; Usi Sukorini
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 51, No 2 (2019)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (201.555 KB) | DOI: 10.19106/JMedSci005102201906

Abstract

Non-alcoholic fatty liver disease (NAFLD) is liver disorders characterized by macrovesicular fatty liver, fibrosis, cirrhosis that not associated with alcohol consumption. The prevalence of NAFLD has risen with a pandemic of obesity. The increase of free fatty acid (FFA) oxidation will induce endoplasmic reticulum stress that cause mitochondrial dysfunction and lead to increase reactive oxygen species (ROS) production causing apoptosis of liver cells. The aim of  study was to determine the prevalence of FFA in the obese group. This was an observational analytical study with cross-sectional design to determine the prevalence ratio of FFA in the obese group with NAFLD compared to the group without NAFLD. Obese women who fulfill the inclusion and exclusion criteria were involved in this study. Five mL venous blood sample was collected for the measurement of lipid profile, liver enzyme and FFA. Fatty liver was evaluated using abdominal USG. The Chi-square test was used to analyze different proportions of FFA between the both groups. Sixty four subjects were participated in this study and classified into obese with NAFLD (39 subjects) and obese without NAFLD (25 subjects). The prevalence ratio of FFA with cutoff value ≥2.66 nmol/mL in the obese group with NAFLD was 4.3 times higher than those without NAFLD (95% IC: 3.5 – 42.3; p<0.001).
The risk of elevated plasma fibrinogen level in hypertensive and normotensive patientsafter bevacizumabintravitreal injection in diabetic retinopathy Ni Luh Putu Widhyasti; Anik Ika Winarni; Natalia Christina Angsana; Rizto Wisuda Senuari; Angela Nurini Agni; Agus Supartoto; Suhardjo Prawiroranu; Tri Wahyu Widayanti; Tatang Talka Gani; Usi Sukorini
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 52, No 1 (2020)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (282.269 KB) | DOI: 10.19106/JMedSci005201202007

Abstract

Bevacizumab intravitreal injection (IVB) could be detected in plasma that might cause an imbalance in the coagulation system. A hypercoagulable state is potentially involved in the risk for thrombosis, which is associated with high cardiovascular mortality.The objective of the current study was to investigate the risk of elevated plasma fibrinogen levelsin hypertensive and normotensive patients after IVB in diabetic retinopathy. This study was conducted at Dr. Sardjito General Hospital, Yogyakarta from March to June 2019. A total of 64 patients were enrolled in the study, included of 32 hypertensive and 32 non-hypertensive patients with diabetic retinopathy who underwent IVB. Patients were interviewed and investigated for physical condition and opthalmological examination. Fibrinogen levelwas measured before and 1 week after IVB. The mean fibrinogen level beforeand after IVB was slightly high in hypertensive patients than normotensive but not significantly different(p>0.05). There was no significant risk of increased fibrinogen levels after IVB in the hypertension group compared to the normotension group in diabetic retinopathy patients. The proportion of patients at high risk for cardiovascular disease after IVB was not significantly different between both groups.
Profil Pemeriksaan Fragilitas Osmotik Eritrosit di RS. Dr. Sardjito Adang Muhammad Gugun; Usi Sukorini
Mutiara Medika: Jurnal Kedokteran dan Kesehatan Vol 4, No 2 (2004)
Publisher : Universitas Muhammadiyah Yogyakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18196/mmjkk.v4i2.1745

Abstract

Osmotic fragility test (OFT) is performed to differentiate anemia diagnose with erythrocyte physical changing. In thalassemia and hemolytic anemia, OFT probably gave variation results that can cause erroneous anemia etiology trac¬ing. Aims of this research are to describe the OFT profile and its comparison with peripheral blood morphology in thalassemia and hemolytic anemia.The method, this retrospective study was conducted in Dr. Sardjito hospital at January 2002 to June 2004. Chi-Square test was used to compare thalassemia and hemolytic anemia proportion in the OFT groups. OFT results from 61 sub¬jects were : increasing 17 (27,8%), increasing-decreasing 17 (27,8%), de¬creasing 15 (24,4%), and normal 12 (20%). There were significantly differ-ence proportions in thalassemia group between decreasing OFT to increasing and normal OFT (p-0,005 ; p=0,002), but no difference to increasing-de¬creasing group. In hemolytic anemia group, the difference proportion found significantly between increasing OFT to normal, increasing-decreasing and decreasing OFT (p=0,03; p-0,005; p=0,000, respectively). In increasing-de¬creasing OFT group, there was no difference in type anemia (p=0,32). Mor¬phologically, target cell was found in 81 % of thalassemia, and spherocyte in 70% of hemolytic anemia. In Dr. Sardjito Hospital, OFT gave variation profile and in Thalassemia and hemolytic anemia groups, morphology evaluation are needed to confirm OFT results.Latar Belakang: Pemeriksaan fragilitas osmotik eritrosit (FOE) ini dilaksanakan untuk membantu diagnosis banding beberapa jenis anemia dengan sifat fisik eritrosit berubah. Aplikasi klinis, Talasemia dan anemia hemolitik memberikan hasil bervariasi sehingga dapat menimbulkan kesalahan interpretasi dalam melacak jenis maupun etiologi anemia.Tujuan penelitian ini adalah mengetahui variasi hasil FOE dan kesesuaian gambaran morfologi darah tepi pada talasemia dan anemia hemolitik. Penelitian retrospektif ini dilakukan menggunakan data rekam medik. Subyek adalah pasien yang diperiksa fragilitas osmotik eritrositnya di laboratorium Patologi Klinik RS. Dr. Sardjito antara Januari tahun 2002 sampai dengan Juni 2004. Uji Chi- square terhadap proporsi talasemia dan anemia hemolitik pada kelompok hasil FOE. Dari 61 subyek, variasi hasil FOE meliputi : peningkatan fragilitas 17 (27,8%), penurunan fragilitas 17 (24,4%), campuran peningkatan dan penurunan 15 (27,8%) dan normal 12 (20%). Terdapat perbedaan bermakna proporsi talasemia kelompok penurunun FOE terhadap kelompok peningkatan FOE (p=0,005) dan FOE normal (p= 0,002), namun tidak berbeda bermakna dengan hasil campuran penurunan dan peningkatan fragilitas (p= 0,26). Terdapat perbedaan bermakna proporsi ane¬mia hemolitik pada kelompok dengan peningkatan FOE terhadap kelompok normal FOE, campuran penurunan dan peningkatan FOE dan penurunan FOE (p =0,03; p= 0,005; p= 0,000). Tidak terdapat perbedaan bermakna proporsi jenis anemia pada hasil campuran penurunan dan peningkatan FOE (p= 0,32). Gambaran morfologi darah tepi pada kelompok talasemia, 81% memiliki sel target dan pada kelompok anemia hemolitik, 70% memiliki sel spherosit.Hasil FOE di RS Dr. Sardjito menunjukkan gambaran variasi, talasemia maupun anemia hemolitik membutuhkan konfirmasi morfologi darah tepi untuk meninjau kesesuaiannya.
High Expression of FcγII (CD32) Receptor on Monocytes in Dengue Infected Patients Umi Solekhah Intansari; Harina Salim; Usi Sukorini; Adika Zhulhi Arjana; Muhammad Juffrie
The Indonesian Biomedical Journal Vol 10, No 3 (2018)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v10i3.434

Abstract

BACKGROUND: Pathogenesis of severe dengue infection has not been elucidated. Immune complex of pre-existing antibodies and heterotypic dengue virus bind to FcγII (cluster of differentiation (CD32)) receptor (FcγIIR) on monocyte facilitates entry and replication of dengue virus. Aim of this study was to evaluate the expression of FcγIIR on monocytes in patients infected with dengue and in healthy subjects.METHODS: This study used a cross-sectional design that included patients infected with dengue who were hospitalized in Dr. Sardjito General Hospital, Panembahan Senopati Hospital, and Sleman Hospital, who met the inclusion criteria and selected consecutively. Examinations were completed using a lyse, no-wash method of flow cytometry. Computerized statistical analysis was conducted and was considered to be significant if p<0.05.RESULTS: Sixty-five study subjects were divided into healthy subjects (24 subjects) and patients with dengue infection (41 subjects). There were no significant differences in hemoglobin (Hb) and hematocrit (Hct) values between the groups, but differences were found in the number of leukocytes, absolute number of monocytes and platelet count (p<0.001, 0.002 and <0.001, respectively). The mean expression of FcγIIR monocytes in patients with dengue infection (208.77±32.06 median fluorescent intensity (MFI)) and the healthy subjects (124.03±47.76 MFI) with p<0.0001.CONCLUSION: The mean expression of FcγIIR monocytes in patients with dengue infection was higher than in healthy subjects.KEYWORDS: dengue infection, FcγII (CD32) receptor monocyte, flow cytometry
DARAH AMAN DAN PENDONOR DARAH SUKARELA (Safe Blood and Voluntary Non-Remunerated Blood Donors) Teguh Triyono; Veronica Fridawati; Usi Sukorini; Budi Mulyono
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 21, No 1 (2014)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v21i1.1253

Abstract

Safe blood was collected from safe, low risk donors with a related absence of infectious disease screening as well. WHO has statedthat to guarantee its safety, blood should only be collected from voluntary non-remunerated blood donors (VNBD) coming from a lowriskpopulation. The aim of this study was to know the blood donors’ profile in Fatmawati Hospital (FH), Jakarta and Dr. SardjitoHospital (SH), Yogyakarta by comparison The research was carried out by cross sectional study and data were obtained from the donor’sinformation records 2011-2013. The data were further descriptively analyzed and presented in tables and graphs. The Student’s t-testwas used to analyze the difference of percentage mean for VNBD per-month between two hospitals with p<0.05. Based on the blooddonor types, it was shown that most of the blood donors consisted of replacement persons. The mean of monthly VNBD percentage wassignificantly higher in FH than in SH. There was an increased VNBD percentage i.e. 32, 35, 54 (FH) and 12, 18, 22 (SH) respectively,within the year 2011, 2012 and 2013.
FCγII (CD32) MONOSIT DI INFEKSI DENGUE PRIMER DAN SEKUNDER {FcγRII (CD32) Monocytes in Primary and Secondary Dengue Infection} Umi S. Intansari; Usi Sukorini; Shanti Ika Sari
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 22, No 1 (2015)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v22i1.1221

Abstract

Dengue infection is a major health problem in the world, including Indonesia. Clinical manifestations of dengue infection varywidely, from asymptomatic until dengue shock syndrome (DSS). Antibody Dependent Enhancement (ADE) hypothesis that states thatnon-neutralizing antibodies in secondary dengue infection may enhance dengue infection via Fcγ receptors is still controversial. Clinicalresearch shows that not all secondary infections manifest as DHF/DSS, but nearly all DHF/DSS cases are caused by secondary infection.Allegedly, the expression of Fcγ has an effect on this incident. This study is an observational analytical study with a cross sectional designto determine the expression of FcγRII (CD32) monocytes in patients with primary and secondary dengue infection. CD32 of monocyteswas measured using FACS Calibur with lyse no wash technique. Primary and secondary dengue infection were determined by IgM/IgGoptical density ratio using ELISA capture method. The ratio of IgM/IgG ≥1.2 was considered as primary infection, while the ratio <1.2was considered as secondary infection. Twenty primary and 32 secondary dengue infection patients in acute phase of dengue infectionpartisipated in this study. Expressions of Fcγ RII (CD32) monocytes were significantly lower in primary than secondary dengue infection(187.825±31.584 vs 218.598±43.414 MFI; p=0.008). CD32 expressions were higher in day 3 compared to day 4 of fever.